FDA Announces New Real-Time Clinical Trial Initiative to Expedite Development, but at What Cost? May 4, 2026 By Mark A. Tobolowsky & James E. Valentine —

https://www.thefdalawblog.com/2026/05/fda-announces-new-real-time-clinical-trial-initiative-to-expedite-development-but-at-what-cost/?utm_source=rss&utm_medium=rss&utm_campaign=fda-announces-new-real-time-clinical-trial-initiative-to-expedite-development-but-at-what-cost On Tuesday, April 28, FDA issued a press release announcing two major steps it is taking to advance the implementation of real-time clinical trials (“RTCTs”), including two proof-of-concept RTCTs, both in oncology, and a Request for Information (“RFI”) for a proposed pilot program.